Azhar, M.H. et al. 2025. Efficacy and Safety of Tailored Dose of BCG (40mg) Versus Standard Dose (80mg) Instillation Therapy in Non-Muscle Invasive Early Bladder Cancer Patients. Biological and Clinical Sciences Research Journal. 6, 10 (Oct. 2025), 74–77. DOI:https://doi.org/10.54112/bcsrj.v6i10.2219.